Redefining Early Stage Investments Conference

Monday, March 24 2014
7:00 am – 8:00 pm

Location: The State Room, Boston, MA

**MassBio members receive a 15% discount! Enter the code “MASSBIO” at registration.**

Click here to learn more & register.

The RESI Conference is poised to be one of the more unique events in the life sciences space this coming spring. This full-day investor partnering conference is groundbreaking in that it is focused on redefining the investor landscape in early stage life sciences. As many in the industry are aware, the nature of early stage life science investments has changed; venture capital has left a void, and there is a plethora of new entities entering the space with capital to allocate.

RESI will host nearly 200 active, early stage investors at the meeting, alongside some of the most influential emerging biotech, pharmaceutical and medical device companies. 

Don't miss all the benefits of attending the Redefining Early Stage Investments Conference:

  • Engage in one-on-one partnering meetings available for the full duration of the day, equaling bandwidth for 600+ meetings (up to 16 per attendee). The RESI partnering system is customized around the conference, and reflects the LSN investor platform’s streamlined search ontology, meaning you will be able to search directly for investors and partners that match your technology.
  • RESI will host a variety of investor panels and free workshops available to conference participants, which are based on cutting-edge content derived from our research of industry investment activity.
  • Additionally, conference partner Nature Publishing Group will host their SciCafe event inside of the RESI Conference.

View the current agenda

 Agenda includes a "Big Pharma and Large Biotech" panel moderated by MassBio's CBO John Hallinan.

**MassBio members receive a 15% discount! Enter the code “MASSBIO” at registration.**

Click here to learn more & register.

 

 

 

http://www.resiconference.com/

 

Share MassBio

 

Janitronics

EvaluatePharma


 

MassBio